CLINICAL TRIAL / NCT05918913

Expanded Access Program for SNDX-5613

  • Expanded Access
  • Recruiting
  • NCT05918913

Expanded Access Program for SNDX-5613 in Patients With Relapsed/Refractory Acute Leukemias With Genetic Alterations Associated With HOXA Overexpression

This expanded access program will provide an investigational treatment option in a controlled clinical setting for patients who are not otherwise eligible to participate in a clinical study and have no approved treatment options.